MarketPeel
Insider Trading Intelligence
AB

Alane P. Barnes

BCRX
CHIEF LEGAL OFFICER · BIOCRYST PHARMACEUTICALS INC · CIK 0001584348
FILING MIX · LIFETIME49%/51%
BUYS
25
SELLS
26
TOTAL VALUE
$7.43M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
463,203
AVG SELL PX
$8.84
TRADE KIND
SHOWING 51 / 51
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 13 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Alane P. Barnes, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+18.18%+8.11%-0.01%+8.12%+6.48%
14d11+36.36%+5.06%-0.30%+5.36%+4.72%
30d11+54.55%+4.91%+1.75%+3.17%-3.12%
60d11+63.64%+10.11%+4.28%+5.83%-6.65%
90d11+27.27%+26.93%+2.39%+24.54%+24.25%
180d11(1 pending)+20.00%+38.94%+13.00%+33.24%+9.09%
1y11(6 pending)+60.00%+26.47%+17.53%+8.94%+13.15%
2y11(6 pending)+60.00%+27.16%+25.97%+1.20%+24.82%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BCRX · 463,203 shares · as of May 13, 2026
0137,676275,352413,027550,703202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 26 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Chief Legal Officer
62,500$5.04$315.0K463,203May 13, 2026May 15, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
62,500$9.54$596.3K400,703May 13, 2026May 15, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
62,5000May 13, 2026May 15, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Chief Legal Officer
150,000$5.51$826.5K550,703Mar 16, 2026Mar 18, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
150,0000Mar 16, 2026Mar 18, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
150,000$9.15$1.37M400,703Mar 16, 2026Mar 18, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
21,773$7.65$166.6K398,751Dec 22, 2025Dec 23, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
16,902$7.41$125.2K420,524Dec 19, 2025Dec 23, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
255,050255,050Dec 17, 2025Dec 19, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
121,700437,426Dec 17, 2025Dec 19, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
21,210$7.65$162.3K315,726Dec 15, 2025Dec 16, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
8,540$7.57$64.6K336,936Dec 12, 2025Dec 16, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
19,770$7.65$151.2K345,476Dec 3, 2025Dec 3, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
50,906$7.21$367.2K365,246Dec 2, 2025Dec 3, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Chief Legal Officer
91,004$3.22$293.0K507,156Dec 1, 2025Dec 3, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
91,0040Dec 1, 2025Dec 3, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
91,004$7.10$646.5K416,152Dec 1, 2025Dec 3, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
250,100250,100Dec 19, 2024Dec 23, 2024View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
2,461$7.39$18.2K412,729Dec 19, 2024Dec 23, 2024View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
120,700415,190Dec 19, 2024Dec 23, 2024View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
8,613$7.53$64.9K294,490Dec 14, 2024Dec 17, 2024View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Chief Legal Officer
5,000$5.53$27.6K300,762May 13, 2024May 15, 2024View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
2,482$6.05$15.0K293,539Dec 19, 2023Dec 20, 2023View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
4,015$6.43$25.8K296,021Dec 14, 2023Dec 18, 2023View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
64,000300,036Dec 14, 2023Dec 18, 2023View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
158,500158,500Dec 14, 2023Dec 18, 2023View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
158,500158,500Dec 19, 2022Dec 21, 2022View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
34,000232,770Dec 19, 2022Dec 21, 2022View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
4,175$10.88$45.4K198,770Dec 15, 2022Dec 19, 2022View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
164,000164,000Dec 14, 2021Dec 16, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
55,000201,969Dec 14, 2021Jan 13, 2022View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
75,000221,969Dec 14, 2021Dec 16, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
35,8520May 12, 2021May 13, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Chief Legal Officer
35,852$4.73$169.6K146,127May 12, 2021May 13, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Chief Legal Officer
1,648$4.73$7.8K111,923May 11, 2021May 13, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
68,0000May 11, 2021May 13, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Chief Legal Officer
68,000$5.45$370.6K213,055May 11, 2021May 13, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Chief Legal Officer
33,132$1.42$47.0K145,055May 11, 2021May 13, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
1,64835,852May 11, 2021May 13, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
33,1320May 11, 2021May 13, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Chief Legal Officer
102,780$12.04$1.24M110,275May 11, 2021May 13, 2021View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
280,000280,000Dec 15, 2020Dec 17, 2020View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Senior VP, Chief Legal Officer
13,741$7.96$109.4K108,061Dec 11, 2020Dec 15, 2020View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Senior VP, Chief Legal Officer
13,741$4.15$57.0K121,802Dec 11, 2020Dec 15, 2020View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Senior VP, Chief Legal Officer
13,7410Dec 11, 2020Dec 15, 2020View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Senior VP, Chief Legal Officer
13,741$6.23$85.6K108,061Dec 4, 2020Dec 8, 2020View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
Senior VP, Chief Legal Officer
13,74113,741Dec 4, 2020Dec 8, 2020View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
Senior VP, Chief Legal Officer
13,741$4.15$57.0K121,802Dec 4, 2020Dec 8, 2020View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
17,00017,000Dec 3, 2020Dec 7, 2020View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,40012,400Feb 21, 2020Feb 25, 2020View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
21,70021,700Feb 14, 2020Feb 19, 2020View →
Other insiders · BCRX
Loading peer insiders…
About this filer
CIK 0001584348
ROLE
Chief Legal Officer
PRIMARY
BCRX
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001584348DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback